Press release
Artificial Pancreas Device System Market Size to Surge to USD 2,005.73 Million by 2035
Where Data Meets Strategic Clarity 📥 View Sample Pages of the Complete Report 👉 https://www.precedenceresearch.com/sample/8214
Market Size and Forecasts:
🔹 Market size in 2025: USD 410.20 Million
🔹 Market size in 2026: USD 480.75 Million
🔹 Market size by 2035: USD 2,005.73 Million
🔹 CAGR: 17.20% (2026-2035)
🔹 Forecast period: 2026-2035
🔹 Base year: 2025
The Role of AI in Advancing Artificial Pancreas Device Systems
AI is revolutionizing the Artificial Pancreas Device System market by enhancing the accuracy and efficiency of glucose level predictions and insulin delivery algorithms. Machine learning algorithms, integrated with these devices, allow for real-time adjustments based on continuously monitored glucose levels, enabling personalized care for patients.
Additionally, AI helps streamline patient data analysis, aiding healthcare professionals in customizing treatment plans. As AI technology continues to evolve, it will provide even more precise control, reducing the risk of diabetes complications and enhancing patient outcomes.
🔗 What's Fueling the Next Wave of Growth? 👉 https://www.precedenceresearch.com/artificial-pancreas-device-system-market
Artificial Pancreas Device System Market Key Growth Drivers
🔸Rising Diabetes Prevalence: With diabetes rates skyrocketing globally, particularly in emerging markets, the demand for efficient and automated diabetes management systems is higher than ever.
🔸Technological Innovation: The rapid development of wearable technologies, advanced sensors, and AI-driven algorithms is improving the reliability, accuracy, and ease of use of artificial pancreas systems.
🔸Increased Healthcare Spending: Growing investments in healthcare, especially in developed regions like North America, are accelerating the adoption of sophisticated medical technologies like artificial pancreas systems.
➡️ Become a valued research partner with us https://www.precedenceresearch.com/schedule-meeting
Artificial Pancreas Device System Market Opportunities
🔸Integration with Digital Tools: The emergence of digital health ecosystems and telemedicine presents new opportunities for integrating artificial pancreas systems with remote monitoring solutions, expanding their reach and effectiveness.
🔸Expansion in Developing Markets: With increasing awareness and government support in regions like Asia-Pacific, there's a growing opportunity to cater to the rising demand for diabetes management solutions in these markets.
Artificial Pancreas Device System Market Trends
The artificial pancreas device system market is rapidly evolving with key technological advancements and shifting healthcare priorities. The adoption of hybrid and fully closed-loop systems, which combine continuous glucose monitoring and automated insulin delivery, is gaining traction.
Furthermore, advancements in AI, machine learning, and cloud-connected systems are improving the precision and adaptability of insulin delivery, transforming diabetes management for millions of patients. The push for home-based diabetes management solutions is also on the rise, as patients seek more convenient and accessible options for real-time glucose control.
🔓 Instant Access. Zero Waiting. 📥 Buy the Premium Market Research Report Now 👉 https://www.precedenceresearch.com/checkout/8214
Artificial Pancreas Device System Market Regional Analysis
North America continues to lead the market, accounting for 41.7% of the global share in 2025. The region's well-established healthcare infrastructure, high adoption of medical technologies, and increasing diabetes awareness are key factors driving this dominance.
Asia-Pacific is set to be the fastest-growing region, thanks to rapid urbanization, increased diabetes rates, and government initiatives to enhance healthcare access. The region's growing healthcare investments are also facilitating the adoption of cutting-edge medical devices.
Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.
Try Before You Buy - Get the Sample Report@ https://www.precedenceresearch.com/sample/8214
Artificial Pancreas Device System Market Segment Analysis
🔹Device Type Analysis
Hybrid closed-loop systems led the market in 2025 with a 38.4% share. Their popularity comes from balancing automation with user control, where basal insulin delivery is automated while users manage mealtime doses. Strong clinical validation, regulatory approvals, and ease of use have made them a preferred choice among patients and healthcare providers.
Fully closed-loop systems are expected to grow at the fastest CAGR of 19.4%. These systems offer complete automation by adjusting insulin delivery in real time without manual intervention. Advancements in sensor accuracy and algorithms are accelerating their path toward commercialization and transforming diabetes management.
🔹Component Analysis
Continuous glucose monitoring (CGM) sensors dominated with a 34.7% share in 2025. Their ability to provide real-time glucose data ensures accurate insulin delivery and improved glycemic control. Increased accuracy, longer wear time, and frequent replacement needs contribute to their strong market presence.
Control algorithms and software are projected to grow at the highest CAGR of 15.7%. Powered by AI and data analytics, these systems optimize insulin dosing and continuously improve performance, enabling better treatment outcomes and real-time monitoring.
🔹Treatment Type Analysis
Insulin-only systems accounted for 86.8% of the market in 2025. Their simplicity, proven clinical effectiveness, and widespread regulatory acceptance have driven strong adoption. These systems are widely available and compatible with existing diabetes technologies.
Bihormonal systems are expected to grow at a CAGR of 18.8%. By combining insulin and glucagon, they provide enhanced glucose control by addressing both high and low blood sugar levels. These systems are still under development and clinical evaluation.
🔹End User Analysis
Home care settings led the market with a 46.8% share in 2025 and are expected to grow steadily. These settings support patient-centric care by enabling continuous treatment in a natural environment, reducing hospital visits and improving convenience.
🔹Age Group Analysis
Adult patients held the largest share at 58.7% in 2025 due to the higher prevalence of diabetes and greater adoption of advanced technologies. Higher purchasing power and availability of tailored solutions further support this segment.
The pediatric segment is projected to grow at the fastest CAGR of 12.9%. Rising awareness of early diabetes management and the need for precise glucose control in children are driving demand for advanced systems.
🔹Distribution Channel Analysis
Direct sales accounted for 41.6% of the market in 2025. This channel allows manufacturers to maintain strong relationships with healthcare providers, ensuring better product training, support, and pricing control.
Online pharmacies are expected to grow at the fastest CAGR of 15.9%. Increasing digitalization, convenience, and accessibility are driving adoption, especially in urban and highly connected regions.
🔹Connectivity and Integration Analysis
Smartphone-integrated systems dominated with a 43.8% share in 2025. These systems allow users to monitor glucose levels, receive alerts, and manage insulin through mobile apps, improving engagement and treatment adherence.
Cloud-connected systems are expected to grow at a CAGR of 14.8%. They enable real-time data sharing, remote monitoring, and advanced analytics, supporting better long-term diabetes management and telehealth integration.
Artificial Pancreas Device System Market Top Companies and Their Offerings
➢Medtronic offers the MiniMed 670G/770G/780G hybrid closed‐loop systems that combine an insulin pump, Guardian/Enlite CGM, and algorithm‐driven automated basal and correction insulin delivery.
➢Insulet Corporation offers the OmniPod 5 artificial‐pancreas‐enabled platform, a tubeless insulin‐pod system linked with Dexcom CGM and an advanced algorithm to provide automated insulin‐delivery.
➢Tandem Diabetes Care offers the t:slim X2 insulin pump with Control‐IQ/Control‐IQ+ AID technology that uses Dexcom CGM data to automatically adjust basal insulin and suspend or correct for glucose excursions.
➢Dexcom offers interoperable CGM systems (G6/G7) that serve as the glucose‐sensing backbone for multiple artificial pancreas device systems by continuously feeding data to compatible pumps.
➢Abbott Laboratories offers FreeStyle Libre and Libre 3 CGM platforms that provide glucose data and analytics often used as the sensing component in external AID or AP‐style ecosystems.
➢Beta Bionics offers the iLet Bionic Pancreas systems that combine an insulin pump (and in some models glucagon delivery) with proprietary algorithms to fully automate insulin and glucagon dosing based on CGM.
➢Senseonics Holdings offers the Eversense/Eversense E3 implantable CGM that provides long‐term continuous glucose data used as an input for external AID or AP platforms.
➢Roche Diabetes Care offers Accu‐Chek devices and mySugr digital tools that support diabetes management and can integrate with pump/CGM data to complement APDS‐style glycemic control.
➢Ypsomed offers the YpsoPump family of small insulin pumps that are used in Europe and other regions and can be integrated into external AID or research‐grade artificial pancreas systems.
➢EOFlow (EoFlow Co., Ltd.) offers the EoFlow AID / EoFlow Smartpatch, a tubeless insulin‐patch pump that pairs with CGM and internal algorithms to deliver automated insulin in a hybrid‐closed‐loop configuration.
➢Diabeloop offers the DBLG1 / DBLG‐system, a smartphone‐based APDS controller that links Dexcom‐type CGM with compatible insulin pumps to enable fully automated insulin delivery.
➢Bigfoot Biomedical offers the Bigfoot Unity / Bigfoot Inject ecosystem, which combines connected insulin pens or injectors with CGM and a smartphone dosing‐decision engine to automate insulin titration.
➢Cellnovo offers the Cellnovo insulin‐pump system and cloud‐based mobile apps mainly used in research‐grade or experimental closed‐loop and AID platforms rather than a branded commercial APDS.
➢Novo Nordisk offers insulin analogs and connected pens along with digital decision‐support tools and collaborates with AID and pump‐CGM partners to optimize insulin use in artificial pancreas environments.
➢Eli Lilly and Company offers insulin analogs and digital diabetes‐management platforms that interface with pump/CGM data and participate in partnerships to refine insulin kinetics for APDS‐style systems.
Recent Advancements in the Market
🔸February 2026: Insulet launched its Omnipod 5 Automated Insulin Delivery System in the Middle East, marking a major milestone in transforming diabetes care with real-time insulin adjustments.
🔸November 2025: Medtronic's MiniMed patch insulin pump received FDA breakthrough device designation, advancing its timeline to enhance diabetes management with less invasive insulin delivery options.
Segments Covered in the Report
🔹By Device Type
Thresholds Suspend Systems
Predictive Low Glucose Suspend Systems
Hybrid Closed-Loop Systems
Advanced Hybrid Closed-Loop Systems
Fully Closed-Loop Systems
🔹By Component
Continuous Glucose Monitoring Sensors
Insulin Pumps
Control Algorithms and Software
Infusion Sets and Consumables
🔹By Treatment Type
Insulin-only Systems
Bihormonal Systems
🔹By End User
Hospitals
Specialty Diabetes Clinics
Home Care Settings
Ambulatory Care Centers
🔹By Age Group
Pediatric Patients
Adult Patients
Geriatric Patients
🔹By Distribution Channel
Direct Sales
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
🔹By Connectivity and Integration
Standalone Systems
Smartphone Integrated Systems
Cloud-connected Systems
🔹By Region
North America
Latin America
Europe
Asia-pacific
Middle and East Africa
Connect With Us
📞 USA: +1 804 441 9344
📞 APAC: +61 485 981 310 or +91 87933 22019 | +6531051271
📞 Europe: +44 7383 092 044
📩 Email: sales@precedenceresearch.com
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
🌐 Web: https://www.precedenceresearch.com
Our Trusted Data Partners:
🔹https://www.towardshealthcare.com
🔹https://www.towardspackaging.com
🔹https://www.towardschemandmaterials.com
🔹https://www.towardsfnb.com
🔹https://www.marketstatsinsight.com
Get Recent News:
https://www.precedenceresearch.com/news
For the Latest Update, Follow Us:
🔹https://www.linkedin.com/company/precedence-research
🔹https://x.com/Precedence_R
🔹https://www.facebook.com/precedenceresearch
🔹https://precedence-research.medium.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Pancreas Device System Market Size to Surge to USD 2,005.73 Million by 2035 here
News-ID: 4441592 • Views: …
More Releases from Precedence Research
Engineering Services Outsourcing Market Size Worth 12.50 Trillion by 2035
The global engineering services outsourcing (ESO) market is witnessing unprecedented growth as organizations across automotive, aerospace, healthcare, industrial manufacturing, consumer electronics, telecommunications, and semiconductor industries increasingly outsource engineering functions to improve operational efficiency, reduce costs, and accelerate product innovation.
Engineering services outsourcing has evolved beyond traditional cost-saving initiatives into a strategic business model that enables enterprises to access specialized engineering talent, adopt advanced digital technologies, and shorten product development cycles.
According to…
Data Center Cooling Market Worth USD 248.21 Billion by 2035
The global data center cooling market is experiencing remarkable growth as organizations worldwide accelerate investments in cloud infrastructure, artificial intelligence (AI), machine learning (ML), high-performance computing (HPC), and edge computing. The increasing density of modern servers and AI training clusters is generating unprecedented heat loads, creating a strong need for innovative cooling technologies that improve energy efficiency, reliability, and operational performance.
According to Precedence Research, the global data center cooling market…
Artificial Intelligence in Cybersecurity Market Forecast to Grow Rapidly at 18.9 …
According to Precedence Research, the artificial intelligence (AI) in cybersecurity market size surpassed USD 29.64 billion in 2025 and is projected to grow from USD 35.40 billion in 2026 to approximately USD 167.77 billion by 2035, registering a robust CAGR of 18.93% during the forecast period from 2026 to 2035.
The rapid rise in ransomware attacks, phishing campaigns, cloud vulnerabilities, and AI-powered cybercrime is accelerating the demand for intelligent cybersecurity platforms…
Control Valves Market Outlook 2035: AI Integration, IoT Connectivity, and Smart …
According to the Precedence Research, the global control valves market size surpassed USD 10.76 billion in 2025 and is projected to increase from USD 11.22 billion in 2026 to approximately USD 16.89 billion by 2035, registering a CAGR of 4.61% during the forecast period (2026-2035).
The increasing adoption of Industry 4.0 technologies, growing implementation of smart manufacturing practices, and rising investments in water treatment, oil & gas, power generation, pharmaceuticals, and…
More Releases for CGM
CGM Underpatch Market to Reach USD 1.2 Billion by 2036 as Rising CGM Adoption an …
Hypoallergenic Tapes Lead with 35.0% Share, Dexcom-Compatible Underpatches Capture 38.0% Market Share, While the United States Emerges as the Fastest-Growing Major Market at 12.9% CAGR
Growing continuous glucose monitor (CGM) adoption, increasing demand for skin-safe adhesive barriers, and expanding direct-to-consumer diabetes accessory ecosystems are accelerating growth in the global CGM Underpatch Market.
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=15435
The global CGM Underpatch Market is projected to grow from USD…
Universal Adhesive Patch For CGM And Insulin Pump
Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days
Waterproof & Reinforced Defense - Pair it with your CGM Blood Glucose Monitoring Sensor [https://www.uwtapes.com/uw-adhesive-patch/] or TruSteel Infusion Kit while showering, bathing, exercising or swimming without worry. Protect your CGM sensor from collisions.
Compatible with CGM sensors and insulin pumps [https://www.uwtapes.com/uw-adhesive-patch/] - ideal for users of closed loop systems. Suitable for…
Global BGM and CGM Market Research Report 2023-2029
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood. Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, on the finger) to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The test is usually referred to as capillary blood glucose. Continuous glucose monitoring automatically tracks blood glucose levels,…
Continuous Glucose Monitoring (CGM) Devices Market Higher convenience offered by …
The CGM displays a glucose trend graph and direction arrows allowing people with diabetes to anticipate approaching glucose highs and lows, thus alerting the wearer during distracted times like playing, sleeping or exercising. The CGM devices market is expected to gain a significant traction in Asia Pacific owing to the collaborations between endocrinologists, credentialed diabetes educators and stakeholder organizations for diabetes prevention.
In 2017, National Diabetes Services Scheme (NDSS) initiated by…
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)…
CMA CGM S. A. - Company Strategy & Performance Analysis
The research report presents a comprehensive assessment of the CMA CGM S. A. and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes.
Purchase the Report at (USD $499 only): https://www.marketinsightsreports.com/report/purchase/0926871550?mode=su?source=openpr&Mode=12
CMA CGM…
